Evidence map›Paper›PMID 36759398›Full record

ArticleAAPS PharmSciTech2023

Vitamin D

Marwa Hasanein Asfour, Sameh Hosam Abd El-Alim, Ahmed Alaa Kassem, Abeer Salama, Amr Sobhi Gouda, Walaa Samy Nazim, Neveen Hassan Nashaat, Maha Hemimi, Nagwa Abdel Meguid

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in AAPS PharmSciTech, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Marwa Hasanein AsfourPharmaceutical Technology Department, National Research Centre, El-Buhouth St., Dokki, 12622, Cairo, Egypt.
Sameh Hosam Abd El-AlimPharmaceutical Technology Department, National Research Centre, El-Buhouth St., Dokki, 12622, Cairo, Egypt. samehhosam@yahoo.com.ORCID http://orcid.org/0000-0001-7554-7682
Ahmed Alaa KassemPharmaceutical Technology Department, National Research Centre, El-Buhouth St., Dokki, 12622, Cairo, Egypt.
Abeer SalamaPharmacology Department, National Research Centre, El-Buhouth St., Dokki, 12622, Cairo, Egypt.
Amr Sobhi GoudaBiochemical Genetics Department, National Research Centre, El-Buhouth St., Dokki, 12622, Cairo, Egypt.
Walaa Samy NazimBiochemical Genetics Department, National Research Centre, El-Buhouth St., Dokki, 12622, Cairo, Egypt.
Neveen Hassan NashaatResearch On Children With Special Needs Department, National Research Centre, El-Buhouth St., Dokki, 12622, Cairo, Egypt.
Maha HemimiResearch On Children With Special Needs Department, National Research Centre, El-Buhouth St., Dokki, 12622, Cairo, Egypt.
Nagwa Abdel MeguidResearch On Children With Special Needs Department, National Research Centre, El-Buhouth St., Dokki, 12622, Cairo, Egypt.
National Research Centre · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the current study is the development of a vitamin D

Indexed as

Autistic DisorderNanoparticlesAnimalsCholecalciferolDrug Delivery SystemsEmulsionsParticle SizeRatsVitamin DCholecalciferolEmulsionsVitamin Dautismnanoemulsionpharmacokineticstoxicityvitamin D3

Identifiers

PMID36759398
OpenAlexW4319662551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.